The development of methodology for clinical measurement of 5-lipoxygenase pathway intermediates from human peripheral blood mononuclear cells

Journal of Pharmaceutical and Biomedical Analysis

Volumn 48, Issue 5, 2008, Pages 1397-1403

  Willey, Mark B ^a   Alborn, William E ^a   Lutzke, Barry S ^a   LeLacheur, Richard M ^b   White, Robert J ^b   Stavrakis, George ^b   Konrad, Robert J ^a   Ackermann, Bradley L ^a  

^a ELI LILLY AND COMPANY   (United States)

^b Taylor Technology Inc   (United States)

Author keywords

5 HETE; 5 LO; Arachidonic acid metabolism; Atherosclerosis; EIA; Inflammation; LC MS MS; LTB4; Methods

Indexed keywords

5 HYDROXYICOSATETRAENOIC ACID; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; CALCIMYCIN; LEUKOTRIENE B4;

ANALYTIC METHOD; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL ISOLATION; CONTROLLED STUDY; ENZYME IMMUNOASSAY; HUMAN; HUMAN CELL; INFLAMMATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METHODOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; VALIDATION PROCESS;

ARACHIDONATE 5-LIPOXYGENASE; CALCIMYCIN; CHROMATOGRAPHY, LIQUID; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; IMMUNOENZYME TECHNIQUES; IONOPHORES; LEUKOCYTES, MONONUCLEAR; LEUKOTRIENE B4; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY; TEMPERATURE; TIME FACTORS;

EID: 58149490986     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2008.09.034     Document Type: Article

References (33)

1. Samuelsson B. Science 220 (1983) 568-575
2. Dixon R.A., Diehl R.E., Opas E., Rands E., Vickers P.J., Evans J.F., Gillard J.W., and Miller D.K. Nature 343 (1990) 282-284
3. Lotzer K., Funk C.D., and Habenicht A.J. Biochim. Biophys. Acta 1736 (2005) 30-37
4. Murphy R.C., and Gijon M.A. Biochem. J. 405 (2007) 379-395
5. Helgadottir A., Manolescu A., Thorleifsson G., Gretarsdottir S., Jonsdottir H., Thorsteinsdottir U., Samani N.J., Gudmundsson G., Grant S.F., Thorgeirsson G., Sveinbjornsdottir S., Valdimarsson E.M., Matthiasson S.E., Johannsson H., Gudmundsdottir O., Gurney M.E., Sainz J., Thorhallsdottir M., Andresdottir M., Frigge M.L., Topol E.J., Kong A., Gudnason V., Hakonarson H., Gulcher J.R., and Stefansson K. Nat. Genet. 36 (2004) 233-239
6. Qiu H., Gabrielsen A., Agardh H.E., Wan M., Wetterholm A., Wong C.H., Hedin U., Swedenborg J., Hansson G.K., Samuelsson B., Paulsson-Berne G., and Haeggstrom J.Z. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 8161-8166
7. Spanbroek R., Grabner R., Lotzer K., Hildner M., Urbach A., Ruhling K., Moos M.P., Kaiser B., Cohnert T.U., Wahlers T., Zieske A., Plenz G., Robenek H., Salbach P., Kuhn H., Radmark O., Samuelsson B., and Habenicht A.J. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 1238-1243
8. Dwyer J.H., Allayee H., Dwyer K.M., Fan J., Wu H., Mar R., Lusis A.J., and Mehrabian M. N. Engl. J. Med. 350 (2004) 29-37
9. Subbarao K., Jala V.R., Mathis S., Suttles J., Zacharias W., Ahamed J., Ali H., Tseng M.T., and Haribabu B. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 369-375
10. Miyahara N., Miyahara S., Takeda K., and Gelfand E.W. Allergol. Int. 55 (2006) 91-97
11. Kowal-Bielecka O., Distler O., Neidhart M., Kunzler P., Rethage J., Nawrath M., Carossino A., Pap T., Muller-Ladner U., Michel B.A., Sierakowski S., Matucci-Cerinic M., Gay R.E., and Gay S. Arthritis Rheum. 44 (2001) 1865-1875
12. Werz O., and Steinhilber D. Pharmacol. Ther. 112 (2006) 701-718
13. Huang L., Zhao A., Wong F., Ayala J.M., Struthers M., Ujjainwalla F., Wright S.D., Springer M.S., Evans J., and Cui J. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 1783-1788
14. Hennig R., Ding X.Z., Tong W.G., Witt R.C., Jovanovic B.D., and Adrian T.E. Cancer Lett. 210 (2004) 41-46
15. Samuelsson B., and Funk C.D. J. Biol. Chem. 264 (1989) 19469-19472
16. Goetzl E.J., An S., and Smith W.L. FASEB J. 9 (1995) 1051-1058
17. Werz O. Curr. Drug Targets Inflamm. Allergy 1 (2002) 23-44
18. Yue H., Jansen S.A., Strauss K.I., Borenstein M.R., Barbe M.F., Rossi L.J., and Murphy E. J. Pharm. Biomed. Anal. 43 (2007) 1122-1134
19. Zhang J.H., Pearson T., Matharoo-Ball B., Ortori C.A., Warren A.Y., Khan R., and Barrett D.A. Anal. Biochem. 365 (2007) 40-51
20. Hedi H., and Norbert G. J. Biomed. Biotechnol. 2004 (2004) 99-105
21. Folco G., and Murphy R.C. Pharmacol. Rev. 58 (2006) 375-388
22. Ford-Hutchinson A.W. Crit. Rev. Immunol. 10 (1990) 1-12
23. Samuelsson B., Dahlen S.E., Lindgren J.A., Rouzer C.A., and Serhan C.N. Science 237 (1987) 1171-1176
24. Almaden Y., Canalejo A., Ballesteros E., Anon, Canadillas S., and Rodriguez M. J. Am. Soc. Nephrol. 13 (2002) 693-698
25. Drazen J.M., Israel E., and O'Byrne P.M. N. Engl. J. Med. 340 (1999) 197-206
26. Abbott B.J., Fukuda D.S., Dorman D.E., Occolowitz J.L., Debono M., and Farhner L. Antimicrob. Agents Chemother. 16 (1979) 808-812
27. Bigby T.D. Mol. Pharmacol. 62 (2002) 200-202
28. Wheelan P., and Murphy R.C. Anal. Biochem. 244 (1997) 110-115
29. Newby C.S., and Mallet A.I. Rapid Commun. Mass Spectrom. 11 (1997) 1723-1727
30. Kempen E.C., Yang P., Felix E., Madden T., and Newman R.A. Anal. Biochem. 297 (2001) 183-190
31. Kita Y., Takahashi T., Uozumi N., and Shimizu T. Anal. Biochem. 342 (2005) 134-143
32. Ford-Hutchinson A.W., Bray M.A., Doig M.V., Shipley M.E., and Smith M.J. Nature 286 (1980) 264-265
33. Lee S.H., Williams M.V., DuBois R.N., and Blair I.A. Rapid Commun. Mass Spectrom. 17 (2003) 2168-2176